Price
CHART BY
Frequently asked questions
What is Sarepta's market capitalization?
The market capitalization of Sarepta is $1.79B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for Sarepta?
Sarepta's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.577. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for Sarepta's stock?
Currently, 28 analysts cover Sarepta's stock, with a consensus target price of $51.84. Analyst ratings provide insights into the stock's expected performance.
What is Sarepta's revenue over the trailing twelve months?
Over the trailing twelve months, Sarepta reported a revenue of $2.23B.
What is the EBITDA for Sarepta?
Sarepta's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$62.10M. EBITDA measures the company's overall financial performance.
What is the free cash flow of Sarepta?
Sarepta has a free cash flow of -$695.31M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does Sarepta have, and what sector and industry does it belong to?
Sarepta employs approximately 1,372 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of Sarepta's shares?
The free float of Sarepta is 93.47M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $1.79B
- EPS (TTM)
- -$2.577
- Free Float
- 93.47M
- Revenue (TTM)
- $2.23B
- EBITDA (TTM)
- -$62.10M
- Free Cashflow (TTM)
- -$695.31M
Pricing
- 1D span
- $18.09$18.31
- 52W span
- $16.90$154.90
Analyst Ratings
The price target is $51.84 and the stock is covered by 28 analysts.
Buy
15
Hold
12
Sell
1
Information
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.
- Employees
- 1,372
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- ISIN
- US8036071004
- Primary Ticker
- SRPT
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet